Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

KRMD US Equity

KORU Medical Systems, Inc.Health Care · Surgical & Medical Instruments & Apparatus · CIK 704440 · FY ends Dec 31
$3.32
-0.01 (-0.30%)
USD · as of 2026-08-19 · marketstack

Legal & controls

5 of 5 annual reports readable here

Item 3 and Item 9A as filed · every verdict is the registrant’s own sentence, printed below it · a filing that fails an extraction gate reads “not extracted”

Fiscal yearFiledItem 3ICFRdisclosure controlsmaterial weaknessFiling
2025-12-312026-03-12described hereeffectiveeffectivenone in Item 9AEDGAR

Item 3 · In the ordinary course of our business, we may be subject to various claims, pending and potential legal actions for damages, investigations relating to governmental laws and regulations and other matters arising out of the normal conduct of our business. We are not aware of any current material pending legal proceedings to which we are a party or of which any of our properties is the subject.

Item 9A · ICFR · Based on this assessment, management determined that, as of December 31, 2025, the Company maintained effective internal control over financial reporting.

Item 9A · disclosure controls · Based on that evaluation, our management, including our CEO and CFO, concluded that as of December 31, 2025, our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and is accumulated and communicated to our management, including our CEO and CFO, to allow timely decisions regarding required disclosure.

2024-12-312025-03-12described hereeffectiveeffectivenone in Item 9AEDGAR

Item 3 · In the ordinary course of our business, we may be subject to various claims, pending and potential legal actions for damages, investigations relating to governmental laws and regulations and other matters arising out of the normal conduct of our business. We are not aware of any current material pending legal proceedings to which we are a party or of which any of our properties is the subject.

Item 9A · ICFR · Based on this assessment, management determined that, as of December 31, 2024, the Company maintained effective internal control over financial reporting.

Item 9A · disclosure controls · Based on that evaluation, our management, including our CEO and CFO, concluded that as of December 31, 2024, our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and is accumulated and communicated to our management, including our CEO and CFO, to allow timely decisions regarding required disclosure.

2023-12-312024-03-13none statedeffectiveeffectivenone in Item 9AEDGAR

Item 3 · None.

Item 9A · ICFR · Based on this assessment, management determined that, as of December 31, 2023, the Company maintained effective internal control over financial reporting.

Item 9A · disclosure controls · Based on that evaluation, our management, including our CEO and CFO, concluded that as of December 31, 2023, our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and is accumulated and communicated to our management, including our CEO and CFO, to allow timely decisions regarding required disclosure.

2022-12-312023-03-08none statedeffectiveeffectivenone in Item 9AEDGAR

Item 3 · None.

Item 9A · ICFR · Based on this assessment, management determined that, as of December 31, 2022, the Company maintained effective internal control over financial reporting.

Item 9A · disclosure controls · Based on that evaluation, our management, including our CEO and CFO, concluded that as of December 31, 2022, our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and is accumulated and communicated to our management, including our CEO and CFO, to allow timely decisions regarding required disclosure.

2021-12-312022-03-02none statedeffectiveeffectivenone in Item 9AEDGAR

Item 3 · None.

Item 9A · ICFR · Based on this assessment, management determined that, as of December 31, 2021, the Company maintained effective internal control over financial reporting.

Item 9A · disclosure controls · Based on that evaluation, our management, including our CEO and CFO, concluded that as of December 31, 2021, our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and is accumulated and communicated to our management, including our CEO and CFO, to allow timely decisions regarding required disclosure.

5 of 5 annual reports on record have their filing text cached on this host; the rest are listed with their EDGAR link and no extraction, because this surface never fetches from SEC on a page load.

  • Item 3 and Item 9A are located in the filing HTML already cached on this host and read with the same line-anchored item matcher and largest-gap body disambiguation the filing-narrative pass uses for Item 1A and Item 7 — no fetch, no model, no summarization.
  • A heading is accepted as a section only when it is not a table-of-contents row (a trailing page number), not a quoted reference in prose, and names its own section; the span must then clear a per-item length band and carry readable text after the heading. Anything that fails a gate is served as 'not extracted' with the reason — never as a default value.
  • An effectiveness conclusion is read only from a sentence that names its own control set (disclosure controls and procedures, or internal control over financial reporting) and states an outcome. Conditional sentences — the standard limitations paragraph and forward-looking remediation language — are excluded, because they are hypotheses rather than conclusions.
  • When a filing's own sentences disagree — an effective conclusion beside an unremediated material-weakness disclosure, or two conclusions of opposite sign — no verdict is asserted. A wrong 'controls were effective' reading is worse than no reading.
  • Every verdict is shown beside the verbatim sentence it was read from. The excerpt is the filing's own words, capped at 1,200 characters; the filing itself is one link away.